Note: Ingredients listed on restricted chemical lists
EC/CAS
203-473-3/107-21-1
Name of the chemical
Ethane-1,2-diol
Concentration
40-60
General Information
Version
2.0
Revision date
2024-12-23
Product name
BARDAHL XCL Evo6 -37
supplier name
SADAPS BARDAHL Additives & Lubricants
Emergency telephone
32 (0)70.245.245, +33 (0)1.45.42.59.59, +353 1 809 2566, +353 1 809 2166, +356 2545 6508, +966 112324180, +966 112324189, +44 20 7188 7188
Icons in SDS
Company Information
company name
SADAPS BARDAHL Additives & Lubricants
e-mail address of the competent person responsible for the Safety Data Sheet
msds@bardahlfrance.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H373
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
No additional information available
Hazard pictograms
GHS07 GHS08
Signal word
Warning
Contains
ethylene glycol Embittering agent Child-resistant fastening Not applicable Tactile warning Applicable
Hazard statements
H302 - Harmful if swallowed. H373 - May cause damage to organs (kidneys) through prolonged or repeated exposure (if swallowed).
Precautionary statements
P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P260 - Do not breathe vapours. P264 - Wash hands thoroughly after handling. P270 - Do not eat, drink or smoke when using this product. P301+P310 - IF SWALLOWED: Immediately call a POISON CENTER, a doctor. P312 - Call a POISON CENTER, doctor if you feel unwell. P501 - Dispose of contents/container to a hazardous or special waste collection point.
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects No additional information available 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] Hazard pictograms (CLP) : GHS07 GHS08
